G1 Therapeutics (GTHX) Financials

$7.15

$0.00 (0.00%)

As on 18-Sep-2024 09:30EDT

Market cap

$377 Mln

Revenue (TTM)

$58 Mln

P/E Ratio

--

P/B Ratio

15.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	58.20	82.51	51.30	31.48	45.29	2.14
Cost of Revenue	6.14	7.20	3.75	2.02	--	0.36
Gross Profit	52.05	75.32	47.55	29.46	45.29	-0.36
Operating Expenses	93.01	114.84	183.73	171.92	141.76	129.04
Operating Profit (EBIT)	-37.88	-39.53	-136.18	-142.46	-96.48	-129.04
Other Income	--	--	-9.68	-4.97	-1.37	6.59
Profit before Tax	-42.96	-44.85	-145.86	-147.43	-97.84	-122.45
Provision for Tax	1.88	3.12	1.70	0.93	1.41	-0.36
Profit after Tax (Net Income)	-44.77	-47.97	-147.56	-148.35	-99.25	-122.09
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-147.56	-148.35	-99.25	-122.45

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	24.59	35.39	68.75	-584.46	-436.11	-336.85
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	36.59	56.44	83.63	82.94	27.76	9.54
Current Liabilities	37.50	29.72	35.59	27.61	23.44	19.77
Total Liabilities	136.19	121.54	187.97	254.09	228.55	284.83

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	5.77	6.59	8.47	10.53	12.16	13.83
Current Assets	92.92	114.95	179.50	243.57	216.39	271.00
Total Assets	136.19	121.54	187.97	-473.91	-384.91	-307.55
Total Debt*	47.96	57.17	83.77	83.06	36.38	10.22
Net Current Assets	55.42	85.23	143.91	215.95	192.95	251.23

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-38.34	-128.62	-132.11	-83.74	-99.57
Cash Flow from Investing Activities	--	--	-50.53	-50.53	0.15	-2.72
Cash from Financing Activities	--	-26.91	52.50	145.86	21.69	2.71
Net Cash Inflow / Outflow	--	--	-126.65	13.76	-61.90	-99.58

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-0.86	-0.92	-3.35	-3.53	-2.61	-3.30
Cash EPS ($)	--	-0.91	-3.34	-3.52	-2.60	-3.29
Adjusted Book Value ($)	--	0.68	1.56	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.74	-2.92	-3.15	-2.20	-2.69
Free Cash Flow per Share ($)	--	-0.74	-2.93	-3.15	-2.20	-2.76

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-39.15	84.59	32.93	27.33	45.13
ROE (%)	-149.29	-92.13	57.23	29.07	25.68	44.30
ROA (%)	-28.16	-31.00	-66.76	-61.47	-38.67	-37.22
EBIT Margin (%)	-65.31	-47.91	-263.99	-455.04	-213.42	-6,029.95
Net Margin (%)	-76.93	-58.13	-354.54	-559.69	-226.00	-1,397.88
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	-34.73	0.61	0.63	-0.30	20.16	--
EBIT Growth (%)	41.93	70.81	5.45	-48.20	25.10	-44.53
Net Profit Growth (%)	45.89	67.49	0.53	-49.47	18.70	-43.15
EPS Growth (%)	53.09	0.72	0.05	-0.35	0.21	-0.28
Book Value Growth (%)	-49.87	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-3.31	-1.62	-2.89	-6.89	-8.01
Price / Book Value	15.34	4.48	3.48	-0.73	-1.57	-2.90
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-6.16	-3.42	-1.32	-2.04	-5.34	-5.59
Close Price ($)	2.28	3.05	5.43	10.21	17.99	26.43
High Price ($)	6.14	8.40	17.49	37.07	26.96	41.80
Low Price ($)	1.08	1.08	3.84	9.75	8.80	13.87
Market Cap ($ Cr)	377.22	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	1.34	1.62	1.22	-0.14	-0.08	-0.03
Short term debt to equity ratio	0.46	0.04	0.02	0.00	-0.04	0.00
Current Ratio	2.48	3.87	5.04	8.82	9.23	13.71
Quick Ratio	2.12	3.45	4.59	8.69	9.23	--
Interest Coverage	-3.80	-3.94	-12.98	-30.69	-54.36	--

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	22.87	15.38	21.63	18.07	0.52	--
Asset Turnover	0.37	0.53	0.23	0.13	0.18	0.01
Receivable days	--	52.64	59.74	34.38	1.91	--
Inventory Days	--	726.46	957.47	314.43	--	--
Payable days	--	289.94	503.24	586.01	--	3,622.23
Cash Conversion Cycle	--	489.16	513.97	-237.21	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.